Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_assertion type Assertion NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_head.
- NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_assertion description "[However, of 109 grade 3 tumors, 0 of 15 POLE-mutant ECs recurred, compared with 29 of 94 (30.9%) POLE wild-type cancers; reflected in statistically significantly greater RFS (multivariable-adjusted HR = 0.11, 95% CI = 0.001 to 0.84, P = .03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_provenance.
- NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_assertion evidence source_evidence_literature NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_provenance.
- NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_assertion SIO_000772 25505230 NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_provenance.
- NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_assertion wasDerivedFrom befree-20150227 NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_provenance.
- NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_assertion wasGeneratedBy ECO_0000203 NP633363.RActiA0QyP2fyFC2IS3VZjeHhiPUUqRYHNLbLVqPsmzqs130_provenance.